Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain - PubMed (original) (raw)
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain
L A Mamounas et al. J Neurosci. 1995 Dec.
Abstract
A pathology of brain serotonergic (5-HT) systems has been found in psychiatric disturbances, normal aging and in neurodegenerative disorders including Alzheimer's and Parkinson's disease. Despite the clinical importance of 5-HT, little is known about the endogenous factors that have neurotrophic influences upon 5-HT neurons. The present study examined whether chronic pain parenchymal administration of the neurotrophins brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) or NGF could prevent the severe degenerative loss of serotonergic axons normally caused by the selective 5-HT neurotoxin p-chloroamphetamine (PCA). The neurotrophins (5-12 micrograms/d) or the control substances (cytochrome c or PBS vehicle) were continuously infused into the rat frontoparietal cortex using an osmotic minipump. One week later, rats were subcutaneously administered PCA (10 mg/kg) or vehicle, and the 5-HT innervation was evaluated after two more weeks of neurotrophin infusion. As revealed with 5-HT immunocytochemistry, BDNF infusions into the neocortex of intact (non-PCA-lesioned) rats caused a substantial increase in 5-HT axon density in a 3 mm diameter region surrounding the cannula tip. In PCA-lesioned rats, intracortical infusions of BDNF completely prevented the severe neurotoxin-induced loss of 5-HT axons near the infusion cannula. In contrast, cortical infusions of vehicle or the control protein cytochrome c did not alter the density of serotonergic axons in intact animals, nor did control infusions prevent the loss of 5-HT axons in PCA-treated rats. NT-3 caused only a modest sparing of the 5-HT innervation in PCA-treated rats, and NGF failed to prevent the loss of 5-HT axon density. The immunocytochemical data were supported by neurochemical evaluations which showed that BDNF attenuated the PCA-induced loss of 5-HT and 5-HIAA contents and 3H-5-HT uptake near the infusion cannula. Thus, BDNF can promote the sprouting of mature, uninjured serotonergic axons and dramatically enhance the survival or sprouting of 5-HT axons normally damaged by the serotonergic neurotoxin PCA.
Similar articles
- BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain.
Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. Mamounas LA, et al. J Neurosci. 2000 Jan 15;20(2):771-82. doi: 10.1523/JNEUROSCI.20-02-00771.2000. J Neurosci. 2000. PMID: 10632606 Free PMC article. - In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion.
Grider MH, Mamounas LA, Le W, Shine HD. Grider MH, et al. J Neurosci Res. 2005 Nov 1;82(3):404-12. doi: 10.1002/jnr.20635. J Neurosci Res. 2005. PMID: 16206279 - Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C. Altar CA, et al. J Neurochem. 1994 Sep;63(3):1021-32. doi: 10.1046/j.1471-4159.1994.63031021.x. J Neurochem. 1994. PMID: 7519657 - Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem.
Popova NK, Naumenko VS. Popova NK, et al. Expert Opin Ther Targets. 2019 Mar;23(3):227-239. doi: 10.1080/14728222.2019.1572747. Epub 2019 Feb 12. Expert Opin Ther Targets. 2019. PMID: 30661441 Review. - Brain-Derived Neurotropic Factor in Neurodegenerative Disorders.
Ibrahim AM, Chauhan L, Bhardwaj A, Sharma A, Fayaz F, Kumar B, Alhashmi M, AlHajri N, Alam MS, Pottoo FH. Ibrahim AM, et al. Biomedicines. 2022 May 16;10(5):1143. doi: 10.3390/biomedicines10051143. Biomedicines. 2022. PMID: 35625880 Free PMC article. Review.
Cited by
- The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review).
Fursa GA, Andretsova SS, Shishkina VS, Voronova AD, Karsuntseva EK, Chadin AV, Reshetov IV, Stepanova OV, Chekhonin VP. Fursa GA, et al. Bull Exp Biol Med. 2024 Aug;177(4):517-527. doi: 10.1007/s10517-024-06218-5. Epub 2024 Sep 12. Bull Exp Biol Med. 2024. PMID: 39266924 Review. - Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats.
Mercado NM, Szarowicz C, Stancati JA, Sortwell CE, Boezwinkle SA, Collier TJ, Caulfield ME, Steece-Collier K. Mercado NM, et al. NPJ Parkinsons Dis. 2024 Aug 23;10(1):163. doi: 10.1038/s41531-024-00771-6. NPJ Parkinsons Dis. 2024. PMID: 39179609 Free PMC article. - The BDNF Val66Met polymorphism and health-related quality of life in youth with obesity.
Goldfield GS, Cameron JD, Sigal RJ, Kenny GP, Prud'homme D, Ngu M, Alberga AS, Doucette S, Goldfield DB, Tulloch H, Thai H, Simas KR, Walsh J. Goldfield GS, et al. Physiol Rep. 2024 Jul;12(13):e16140. doi: 10.14814/phy2.16140. Physiol Rep. 2024. PMID: 38997217 Free PMC article. - Advances in the study of the relationship between Alzheimer's disease and the gastrointestinal microbiome.
Li XY, Qin HY, Li TT. Li XY, et al. Ibrain. 2022 Sep 8;8(4):465-475. doi: 10.1002/ibra.12065. eCollection 2022 Winter. Ibrain. 2022. PMID: 37786585 Free PMC article. Review. - Neurotrophin signalling in the human nervous system.
Ateaque S, Merkouris S, Barde YA. Ateaque S, et al. Front Mol Neurosci. 2023 Jul 4;16:1225373. doi: 10.3389/fnmol.2023.1225373. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37470055 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous